OriGene Technologies acquires Acris Antibodies - MarketLine Financial Deals

OriGene Technologies acquires Acris Antibodies

OriGene Technologies acquires Acris Antibodies - MarketLine Financial Deals
OriGene Technologies acquires Acris Antibodies
Published Oct 28, 2015
2 pages — Published Oct 28, 2015
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

OriGene Technologies, Inc., a US-based developer, manufacturer, and seller of genome wide research and diagnostic products, has acquired Acris Antibodies GmbH.

  
Source:
Document ID
MA161251_151029
Country
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "OriGene Technologies acquires Acris Antibodies" Oct 28, 2015. Alacra Store. Dec 10, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/OriGene-Technologies-acquires-Acris-Antibodies-2052-114782>
  
APA:
MarketLine Financial Deals. (2015). OriGene Technologies acquires Acris Antibodies Oct 28, 2015. New York, NY: Alacra Store. Retrieved Dec 10, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/OriGene-Technologies-acquires-Acris-Antibodies-2052-114782>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.